DWA
NBP

Dorsey Wright & Associates’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Dorsey Wright & Associates’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-69,882
Closed -$5.07M – 303
2021
Q3 		$5.07M Buy
+69,882
New +$5.05M 1.11% 23

Other funds holding NBP

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ZAM
Zeal Asset Management Central, Hong Kong $39.4M AUM 38.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dorsey Wright & Associates's NBP Position: Q4 2021 in Review

Dorsey Wright & Associates sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2021, closing a stake of 69,882 shares — an estimated $5.07M sold.

Dorsey Wright & Associates first reported a position in NBP in Q3 2021 and held it in 1 quarter. The position peaked at $5.07M in Q3 2021. 132 funds tracked by Wall St. Rank hold NBP as of Q4 2021.

  • Dorsey Wright & Associates reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Dorsey Wright & Associates sold 69,882 NovaBridge Biosciences American Depositary Shares shares in Q4 2021, an estimated $5.07M.
  • Dorsey Wright & Associates first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2021 and held it in 1 quarter.
  • Dorsey Wright & Associates's NovaBridge Biosciences American Depositary Shares position peaked at $5.07M in Q3 2021.
  • 132 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2021.

Based on Dorsey Wright & Associates's 13F filing for Q4 2021, filed 27 Jan 2022.